Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Ducommun Incorporated is an aerospace & defense business based in the US. Ducommun Incorporated shares (DCO) are listed on the NYSE and all prices are listed in US Dollars. Ducommun Incorporated employs 2,450 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$48.64|
|52-week range||$31.36 - $65.40|
|50-day moving average||$50.73|
|200-day moving average||$54.27|
|Wall St. target price||$70.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.58|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-1.32%|
|1 month (2021-09-23)||-3.15%|
|3 months (2021-07-23)||-9.30%|
|6 months (2021-04-23)||-15.96%|
|1 year (2020-10-22)||39.97%|
|2 years (2019-10-22)||22.43%|
|3 years (2018-10-22)||25.07%|
|5 years (2016-10-21)||138.20%|
Valuing Ducommun Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ducommun Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ducommun Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Ducommun Incorporated shares trade at around 19x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Ducommun Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.339. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ducommun Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ducommun Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $75.4 million.
The EBITDA is a measure of a Ducommun Incorporated's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$625.5 million|
|Operating margin TTM||7.57%|
|Gross profit TTM||$137.7 million|
|Return on assets TTM||3.54%|
|Return on equity TTM||9.55%|
|Market capitalisation||$587.6 million|
TTM: trailing 12 months
There are currently 172,466 Ducommun Incorporated shares held short by investors – that's known as Ducommun Incorporated's "short interest". This figure is 0.1% down from 172,700 last month.
There are a few different ways that this level of interest in shorting Ducommun Incorporated shares can be evaluated.
Ducommun Incorporated's "short interest ratio" (SIR) is the quantity of Ducommun Incorporated shares currently shorted divided by the average quantity of Ducommun Incorporated shares traded daily (recently around 41161.336515513). Ducommun Incorporated's SIR currently stands at 4.19. In other words for every 100,000 Ducommun Incorporated shares traded daily on the market, roughly 4190 shares are currently held short.
However Ducommun Incorporated's short interest can also be evaluated against the total number of Ducommun Incorporated shares, or, against the total number of tradable Ducommun Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ducommun Incorporated's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Ducommun Incorporated shares in existence, roughly 10 shares are currently held short) or 0.0159% of the tradable shares (for every 100,000 tradable Ducommun Incorporated shares, roughly 16 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ducommun Incorporated.
Find out more about how you can short Ducommun Incorporated stock.
We're not expecting Ducommun Incorporated to pay a dividend over the next 12 months.
Ducommun Incorporated's shares were split on a 3:2 basis on 10 June 1998. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Ducommun Incorporated shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Ducommun Incorporated shares which in turn could have impacted Ducommun Incorporated's share price.
Over the last 12 months, Ducommun Incorporated's shares have ranged in value from as little as $31.36 up to $65.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ducommun Incorporated's is 1.6037. This would suggest that Ducommun Incorporated's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ducommun Incorporated provides engineering and manufacturing products and services primarily to the aerospace and defense, industrial, medical, and other industries in the United States. It operates through two segments, Electronic Systems and Structural Systems. The Electronic Systems segment provides cable assemblies and interconnect systems; printed circuit board assemblies; higher-level electronic, electromechanical, and mechanical components and assemblies, as well as lightning diversion systems; and radar enclosures, aircraft avionics racks, shipboard communications and control enclosures, shipboard communications and control enclosures, wire harnesses, surge suppressors, conformal shields, and other assemblies. It also supplies engineered products, including illuminated pushbutton switches and panels for aviation and test systems; microwave and millimeter switches and filters for radio frequency systems and test instrumentation; and motors and resolvers for motion control. In addition, this segment provides engineering expertise for aerospace system design, development, integration, and testing. The Structural Systems segment designs, engineers, and manufactures contoured aluminum, titanium, and Inconel aero structure components; structural assembly products, such as winglets, engine components, and fuselage structural panels; and metal and composite bonded structures and assemblies comprising aircraft wing spoilers, large fuselage skins, rotor blades on rotary-wing aircraft and components, flight control surfaces, engine components, and ammunition handling systems. It serves commercial aircraft, military fixed-wing aircraft, military and commercial rotary-wing aircraft, and space programs, as well as industrial, medical, and other end-use markets.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.